ASMC'07 St. Petersburg 27/08/2007
Optional tours between 09.00-18.00 / Pushkin (Amber room) + Pavlovsk Palaces, three Cathedrals (tbc), Canals
Transfers from the airport between 12.00-19.00
14:00 Registration
19:30 Welcome reception
28/08/2007
08:30 Opening
09:10 The Changing Face of Organic Synthesis
Prof. Steven V. LEY (UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom)
10:00 Protecting Group Directed Ring-Closing Metathesis (RCM):
the First Total Synthesis of Anti-Malarial Nonenolide
Dr. Mukund S. CHORGHADE (CHORGHADE ENTERPRISES, NATICK, United States)
10:15 Coffee-break
10:45 Discovery of Innovative Small Molecule Therapeutics
Prof Magid ABOU-GHARBIA (TEMPLE UNIVERSITY, Philadelphia, United States)
11:35 The Discovery of Novel Antiviral Agents
Dr. Joe VACCA (MERCK & CO., West Point, United States)
12:05 Ultra-High-Throughput Screening for Lead Discovery: Impact of Combinatorial Chemistry Compound Libraries
Dr. Stefan MUNDT (BAYER HEALTHCARE, Elberfeld, Germany)
12:35 A Combinatorial Approach to Probe the Mechanism of Binding of Bivalent Ligands to GPCRs
Ms Kimberly BONGER (LEIDEN UNIVERSITY, Leiden, The Netherlands)
12:50 Lunch
14:00 Polyfunctional Zn,Mg-Organometallics for Organic Synthesis
Prof. Paul KNOCHEL (LUDWIG MAXIMILIANS UNIVERSITY, Munchen, Germany)
14:50 Innovation in Drug Discovery and Development Interface
Dr. Balu BALASUBRAMANIAN (BRYSTOL-MYERS SQUIBB, Princeton New Jersey 08543, United States)
15:20 From Adrenomedullin Positive Modulators to A New Type Of Mmp-2 Inhibitors
Dr. Beatriz DE PASCUAL-TERESA (UNIVERSIDAD SAN PABLO CEU, Madrid, Spain)
15:35 Coffee-break
16:05 Surprises and Discoveries with Natural Products
Prof. Erick M. CARREIRA (ETH ZÜRICH, Zürich, Switzerland)
16:55 Discovery of Bile Acid Resorption Inhibitors
(EYEDPHARMA)
17:25 Tetracyclic Indole Inhibitors of Hepatitis C Virus Ns5b-Polymerase
Dr. Ian STANSFIELD (IRBM MERCK, Pomezia Roma, Italy)
17:40 Metal-Catalyzed Coupling Reactions
Prof. Gregory C. FU (MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Pasadena, United States)
19:30 City tour for participants
29/08/2007
08:30 A Tale of Two Proteases
Dr Scott A. BILLER (NOVARTIS, Cambridge, United States)
09:20 Positive and Negative Modulation of Family C GPCRs
Prof. Tanja WEIL (ULM UNIVERSITY, Ulm, Germany)
09:50 New Sugar-Derived Compounds with Anti-Septic Shock, Anti-Inflammatory and Anti-Ischemia Activity
Dr. Francesco PERI (UNIVERSITY OF MILANO/BICOCCA, Milano, Italy)
10:05 Coffee-break
10:35 Genomic and Nongenomic Bile Acid Receptors as New Targets for Drug Discovery
Prof. Roberto PELLICCIARI (UNIVERSITY OF PERUGIA & EFMC, Perugia, Italy)
11:25 The Identification of Secretase Inhibitors for the Treatment of Alzheimer's Disease
Dr. John ELLINGBOE (WYETH RESEARCH, Pearl River, United States)
11:55 Where Chemistry meets Sphingolipid Biology
(EYEDPHARMA)
12:25 Synthesis of Fosmidomycin Analogues Modified at the Three-Carbon Spacer: Towards Potent Antimalarials
Prof. Serge VAN CALENBERGH (UGENT, Ghent, Belgium)
12:40 Lunch & Poster session
BUSINESS MINI SYMPOSIUM: Discovery Chemistry Outsourcing Opportunities in Russia
14:00 Opening
Dr Gene VAISBERG (CHEMBRIDGE CORPORATION, San Diego, United States)
A Renewed Emphasis on Partnerships, With a Twist; The Challenge to Meet the Ever Evolving Pharma Landscape
Dr. Michael CLARK (PFIZER, New London, United States)
Discovery Chemistry Sourcing in Russia. How Does it Compare to Other Regions of the World?
Dr. Richard D. CONNELL (PFIZER, Groton, United States)
Outsourcing Parts of the Discovery Value Chain in Russia
Dr Frederik DEROOSE (JOHNSON & JOHNSON PHARMACEUTICALS, Destelbergen, Belgium)
The AstraZeneca Compound Collection Enhancement Programme - Outsourcing in Russia
Dr. Garry PAIRAUDEAU (ASTRAZENECA R&D MÖLNDAL, Möndal, Sweden)
Outsourcing in Russia: the UCB Experience
Dr. Patrice TALAGA (UCB, Braine-L'Alleud, Belgium)
Discovery Chemistry CROs: The Art of Playing on the Fast Changing Field
Dr Gene VAISBERG (CHEMBRIDGE CORPORATION, San Diego, United States)
16:05 Coffee-break
Panel discussion participants
B. BALASUBRAMANIAN (BMS, US), M. CLARK (Pfizer, US), R.D. CONNELL (Pfizer, US), F. DEROOSE (J&J Pharmaceuticals, Belgium), D. STOUT (Merck, US), W.B. KNIGHT (GSK, US), G. PAIRAUDEAU (AstraZeneca, UK), P. TALAGA (UCB, Belgium), G. VAISBERG (ChemBridge)
19:00 City tour for participants
30/08/2007
08:30 New Approaches to Biologically Validated Molecules using Chemoselective Ligation Reactions
Prof. Alessandro DONDONI (UNIVERSITY OF FERRARA, Ferrara, Italy)
09:20 Discovery of Aclidinium Bromide, a New Long-Acting Muscarinic Antagonist for COPD Therapy
Dr. Hamish RYDER (ALMIRALL, Barcelona, Spain)
09:50 Novel Multilabeled Oligonucleotides Containing 1-phenylethynylpyrene ara-2´-uridine-carbamate and LNA: Synthesis and Photochemical Properties
Dr. Irina ASTAKHOVA (NUCLEIC ACID CENTER, DEPARTMENT OF PHYSICS AND CHEMISTRY, Odense M, Denmark)
10:05 Coffee-break
10:35 Modern Protein Chemistry
Prof. Ron RAINES (UNIVERSITY OF WISCONSIN, Madison, United States)
11:25 Exploiting High Throughput Screening: Case Histories
Dr Paul LEESON (PAUL LEESON CONSULTING LTD., United Kingdom)
11:55 Design and Synthesis of Thrombin Receptor Antagonists for the Prevention of Thrombosis
Dr William J. GREENLEE (SCHERING-PLOUGH RESEARCH INSTITUTE, United States)
12:45 Lunch
Free afternoon - optional tours to Hermitage, Russian Museum, 3 Cathedrals and Canals
31/08/2007
08:30 Chemical Probes of Carbohydrate Biosynthetic Pathways in Mycobacterium Tuberculosis
Prof. Laura KIESSLING (UNIVERSITY OF WISCONSIN-MADISON, Madison, United States)
09:20 Discovery and Development of Kinase Iinhibitors by Targeting Conformational Switch Pockets. A General Platform that is Unique for Targeting ATP Pockets
Dr. Peter A. PETILLO (DECIPHERA PHARMACEUTICALS, Lawrence, United States)
09:50 Synthesis of (±)-Cephalotaxine via Diallylboration-Ring Closing Metathesis-Bromocyclocarbamation Sequence
Dr Nikolai KUZNETSOV (INEOS RAS, Moscow, Russia)
10:05 Coffee-break
10:35 SAHA (Vorinostat), an FDA Aapproved Anticancer Compound with a Novel Mechanism of Action
Prof. Ronald BRESLOW (COLUMBIA UNIVERSITY, New York, United States)
11:25 The Fight Against AIDS: New Avenues for Inhibiting RT, an Old Target
Prof. Maurizio BOTTA (UNIVERSITY OF SIENA, Siena, Italy)
11:55 Adventures in Medicinal Chemistry
Dr Anthony WOOD (PFIZER, Cambridge, United States)
12:25 Smiles Rearrangement and Isocyanide Chemistry
Dr. Laurence GRIMAUD (ENSTA, PARIS, France)
12:40 Lunch & Poster session
14:00 Transition Metal Catalyzed Reactions of Carbon-Carbon and Carbon-Heteroatom Bond Formation
Prof. Irina P. BELETSKAYA (MOSCOW STATE UNIVERSITY, Moscow, Russia)
14:50 The Power of Semi-Synthesis: The Discovery of Torisel ™
Dr. Jerauld S. SKOTNICKI (WYETH RESEARCH, Pearl River, United States)
15:20 Synthesis and Characterisation of Novel Orally Available Dopamine D3 Receptor Antagonists
Dr. Sean TURNER (ABBOTT GMBH, LUDWIGSHAFEN, Germany)
15:35 Coffee-break
16:05 A Systems Based Approach to Protein Kinase Research Leads to the Discovery of Tykerb, a Dual Inhibitor of EGFR and erbB2 Tyrosine Kinases
Dr. Wilson B. KNIGHT (GSK, Research Triangle Park, United States)
16:35 The Inner Space of Molecules
Prof. Julius REBEK (SCRIPPS RESEARCH INSTITUTE, La Jolla, United States)
17:25 Olefin Metathesis Catalysts for the Synthesis of Large and Small Molecules
Prof. Robert H. GRUBBS (CALIFORNIA INSTITUTE OF TECHNOLOGY, Pasadena, United States)
18:15 Closing
19:00 Symposium banquet (optional)
Following the banquet, Open bridges tour(optional)
01/09/2007
08:30 Transfers to the airport
Optional tours between 9.00-18.00 / Canals, Petergof, Hermitage, Pushkin (Amber room) + Pavlovsk Palaces (tbc), Russian Museum (tbc)
<Previous page